A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.
by Goulart, Bernardo

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2011 Sep-Oct, Vol.14(6), pp.836-845


Cost-effectiveness analysis of the addition of bevacizumab to chemotherapy as induction and maintenance therapy for metastatic non-squamous non-small-cell lung cancer.
by Zheng, H

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, March 2018, Vol.20(3), pp.286-293


Cost-effectiveness of pemetrexed as first-line maintenance therapy for advanced nonsquamous non-small cell lung cancer.
by Klein, Robert

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, August 2010, Vol.5(8), pp.1263-1272


Anti-angiogenesis drugs in lung cancer.
by Lee, Siow Ming

Respirology (Carlton, Vic.), April 2010, Vol.15(3), pp.387-392


Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 13 Hits

Remove Filters